Loading
Talking Medicines
Talking Medicines is a healthcare intelligence company based in Glasgow, founded in 2013. The company specializes in AI-powered conversational data intelligence, focusing on capturing and analyzing the "voice of the patient" to enhance pharmaceutical marketing and improve patient outcomes. Their mission is to utilize patient voice data from social media, forums, and connected devices to assist pharmaceutical companies in making informed decisions that boost engagement and treatment results. The company offers a range of technology tools, including PatientMetRx®, an advanced social intelligence platform that structures patient voices related to over 130,000 regulated medicines. Other offerings include Drug-GPT, an AI-driven interface for accessing insights on pharmaceutical brands, and MedSmart, a mobile app designed to help users manage allergies and medication interactions. Talking Medicines serves global pharmaceutical companies, healthcare advertising agencies, and healthcare marketing agencies, while also engaging directly with consumers through its MedSmart app.
Funding
Every round, secondary, debt facility or acquisition involving Talking Medicines that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$2M